Bibliography
- American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 5th edition. American Psychiatric Press; Washington, DC: 2014
- Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45(12):1094-9
- Hollander E, Stein D. Obsessive-compulsive disorder. Oxford Press; New York: 1999
- Lopez-Ibor JJ, Fernandez-Cordobe E. La monclomipramina en-enfermos resistentes a otros tratamiantos. Acta Luso-Espan Neurol Psiquiatria 1967;26:119-47
- Montgomery SA. Pharmacological treatment of obsessive-compulsive disorder. In: Hollander E, Zohar J, Marazziti D, Oliver B, editors. Current insights in obsessive-compulsive disorder. Wiley & Sons; Chichester: 1994. p. 215-26
- Zohar J, Chopra M, Sasson Y, et al. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000;1(2):92-100
- NICE. Obsessive-compulsive disorder: care interventions in the treatment of obsessive-compulsive disorder and body-dysmorphic disorder. National Collaborating Centre for Mental Health. Publ. British Psychological Society and the Royal College of Psychiatrists; UK: 2006
- Bandelow B, Sher L, Bunevicius R, et al. WFSBP task force on mental Disorders in Primary care, WSFSBP task force on anxiety disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16:77-84
- Marazziti D, Consoli G. Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother 2010;11:331-43
- Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post- traumatic stress disorders - first revision. World J Biol Psychiatry 2008;9:248-312
- Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry 1991;48:730-8
- Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993;306:683-7
- Danish University Antidepressant Group (DUAG). Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology(Berl) 1986;90:131-8
- Danish University Antidepressant Group (DUAG). Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-99
- Marazziti D, Akiskal HS, Udo M, et al. Dimorphic changes of some features of loving relationships during long-term use of antidepressants in depressed outpatients. J Affect Disord 2014;166:151-5
- Dold M, Aigner M, Lanzenberger R, et al. Antipsychotic argumentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 2012;29:1-12
- Marazziti D. Psicofarmacoterapia clinica. 5th edition. Fioriti ed; Rome: 2013
- Walbeck K, McDaid D. Actions to alleviate the mental health impact of the economic crisis. World Psychiatry 2012;11:139-45